As a cyclic disulfide-containing peptide, AOD-9604 warrants standard handling considerations for cysteine-bearing sequences, including protection from oxidative and reductive conditions during reference-standard preparation, and storage of the lyophilizate under cool, dry, light-protected conditions to preserve analytical integrity
Glutathione acts as a frontline defender, neutralising reactive oxygen species (ROS) that damage collagen, elastin, and DNA
One is Third Party manufacturing wherein Ricaptos manufacture the products for Various Pharma marketing companies across India under their brand names
CagriSema submitted for FDA approval in December 2025 with expected approval in Q4 2026 or Q1 2027, meaning launch around mid-2027
Adjust based on your specific protocol needs, syringe size, and comfort with injection volumes